Dr. Geraldine Deliencourt-Godfrey reports

SIRONA BIOCHEM RECEIVES COMMERCIAL-GRADE GLYCOPROTEMIM BASED ANTI-AGING SERUM FORMULATIONS

Sirona Biochem Corp. has made a significant achievement in its quest to transform the skin care industry. Its subsidiary, TFChem, has successfully received formulations for its eagerly awaited GlycoProteMim-based anti-aging serum from its formulation partner, Global Beauty Consulting (GBC). This marks a crucial step in Sirona Biochem's plan to offer innovative skin care solutions.

The chosen formulation will not only define the brand but also lay the foundation for a broader range of products. The team is in the process of selecting the precise formulation that will undergo standard safety evaluations and be used in the coming clinical trial. This is in preparation for the planned product launch in early 2025, ensuring compliance with regulatory standards in the European, U.S. and Canadian markets.

"We are thrilled to unveil these innovative formulations for our GlycoProteMim-based anti-aging serum. Our mission at Sirona Biochem is to revolutionize skin care through science and these formulations represent a significant step towards achieving that goal," reports Sirona's chief scientific officer, Dr. Geraldine Deliencourt-Godfrey. "In line with our commitment to transparency and innovation, samples of the GlycoProteMim-based anti-aging serum formulations will be distributed to prospective key stakeholders in Asia, Europe and North America."

About Sirona Biochem Corp.

Sirona is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments. Sirona's laboratory, TFChem, is in France and is the recipient of multiple French national scientific awards and European Union and French government grants.

We seek Safe Harbor.